ORGANIC
LETTERS
A Synthesis of the Welwistatin Core§
2006
Vol. 8, No. 23
5287-5289
Ryan Lauchli and Kenneth J. Shea*
Department of Chemistry, 1102 Natural Sciences II, UniVersity of California,
IrVine, IrVine, California 92697-2025
Received August 22, 2006
ABSTRACT
An approach to the core structure of the microtubule-targeting agent welwistatin is described. The approach utilizes the type 2 intramolecular
Diels Alder reaction, with indole serving as the tether between diene and dienophile, to form the natural product’s characteristic bicyclo-
−
[4.3.1]decane skeleton.
Despite the success of microtubule-targeting agents pacli-
taxel, vinblastine, and colchicine as cancer therapeutics, the
effectiveness of these treatments is diminished in many
instances by multiple drug resistance (MDR).1 The mecha-
nism of MDR is thought to be overexpression of P-
glycoprotein, which acts as a drug efflux pump. The
antimicrotubule agent welwistatin has shown the unique
characteristic of maintaining its antimicrotubule properties
in laboratory cell lines, even when those cell lines had MDR
and overexpressed P-glycoprotein. This enhanced cytotoxic
action demonstrates that welwistatin may be effective as an
anticancer drug.
dolinone A has been synthesized by impressive efforts of
two groups, no members of the welwistatin structural class
have yielded to total synthesis to date.3 Recently, several
core structure syntheses have been disclosed, emphasizing
the significant interest in synthesizing this challenging
molecule.4 The complex architecture of welwistatin com-
prises 4 stereocenters, 3 quaternary carbons including 2
which are vicinal, a sensitive vinyl chloride, and an imbedded
bicyclo[4.3.1] ring system. We hypothesized that this bicyclo-
[4.3.1] system could be accessed through a type 2 intramo-
lecular Diels-Alder (T2IMDA) cyclization by using the
indole framework to tether the diene and dienophile (Scheme
(2) (a) Stratmann, K.; Moore, R. E.; Bonjouklian, R.; Deeter, J. B.;
Patterson, G. M. L.; Shaffer, S.; Smith, C. D.; Smitka, T. A. J. Am. Chem.
Soc. 1994, 116, 9935. (b) Jimenez, J. I.; Huber, U.; Moore, R. E.; Patterson,
G. M. L. J. Nat. Prod. 1999, 62, 569.
(3) (a) Baran, P. S.; Richter, J. M. J. Am. Chem. Soc. 2005, 127, 15394.
(b) Reisman, S. E.; Ready, J. M.; Hasuoka, A.; Smith, C. J.; Wood, J. L.
J. Am. Chem. Soc. 2006, 128, 1448.
(4) (a) Konopelski, J. P.; Deng, H.; Scheimann, K.; Keane, J. M.;
Olmstead, M. M. Synlett 1998, 1105. (b) Wood, J. L.; Holubec, A. A.;
Stoltz, B. M.; Weiss, M. M.; Dixon, J. A.; Doan, B. D.; Shamji, M. F.;
Chen, J. M.; Heffron, T. P. J. Am. Chem. Soc. 1999, 121, 6326. (c) Kaoudi,
T.; Quiclet-Sire, B.; Seguin, S.; Zard, S. Z. Angew. Chem., Int. Ed. 2000,
39, 731. (d) Konopelski, J. P.; Deng, H. Org. Lett. 2001, 3, 3001. (e) Jung,
M. E.; Slowinski, F. Tetrahedron Lett. 2001, 42, 6835. (f) Lo´pez-Alvarado,
P.; Garc´ıa-Granda, S.; AÄ lvarez-Ru´a, C.; Avendan˜o, C. Eur. J. Org. Chem.
2002, 1702. (g) Ready, J. M.; Reisman, S. E.; Hirata, M.; Weiss, M. M.;
Tamaki, K.; Ovaska, T. V.; Wood, J. L. Angew. Chem., Int. Ed. 2004, 43,
1270. (h) MacKay, J. A.; Bishop, R. L.; Rawal, V. H. Org. Lett. 2005, 7,
3421. (i) Baudoux, J.; Blake, A. J.; Simpkins, N. S. Org. Lett. 2005, 7,
4087. (j) Greshock, T. J.; Funk, R. L. Org. Lett. 2006, 8, 2643. (k) For a
review, see: Avendan˜o, C.; Mene´ndez, J. C. Curr. Org. Synth. 2004, 1,
65.
Welwistatin is an alkaloid isolated from blue-green algae,
along with several related compounds.2 Though welwitin-
§ Dedicated to the memory of the late Dr. Vinayak Kane.
(1) (a) Smith, C. D.; Zilfou, J. T.; Stratmann, K.; Patterson, G.; Moore,
R. E. Mol. Pharm. 1995, 47, 241. (b) Zhang, X.; Smith, C. D. Mol. Pharm.
1996, 49, 288. (c) Jordan, M. A.; Wilson, L. Nature ReV. Cancer 2004, 4,
253.
10.1021/ol0620747 CCC: $33.50
© 2006 American Chemical Society
Published on Web 10/13/2006